The microbial epigenome in metabolic syndrome

Molecular Aspects of Medicine

Volumn 54, Issue , 2017, Pages 71-77

  Remely, Marlene ^a   Haslberger, Alexander G ^a  

^a UNIVERSITY OF VIENNA   (Austria)

Author keywords

DNA methylation; Firmicutes Bacteroidetes ratio; Obesity; SCFAs

Indexed keywords

G PROTEIN COUPLED RECEPTOR; HISTONE DEACETYLASE; TOLL LIKE RECEPTOR;

DISEASE ASSOCIATION; DNA MODIFICATION; EPIGENETICS; HUMAN; INTESTINE FLORA; METABOLIC SYNDROME X; METABOLITE; MICROBIAL GENOME; MICROBIAL METABOLISM; NONHUMAN; REVIEW; SPECIES COMPOSITION; ANIMAL; BIOLOGICAL MODEL; GENETIC EPIGENESIS; GENETICS; METABOLISM; METABOLOME; MICROBIOLOGY;

ANIMALS; EPIGENESIS, GENETIC; GASTROINTESTINAL MICROBIOME; HUMANS; METABOLIC SYNDROME; METABOLOME; MODELS, BIOLOGICAL; TOLL-LIKE RECEPTORS;

EID: 84992426192     PISSN: 00982997     EISSN: 18729452     Source Type: Journal    
DOI: 10.1016/j.mam.2016.09.003     Document Type: Review

References (87)

1. Aumueller, E., Remely, M., Baeck, H., Hippe, B., Brath, H., Haslberger, A.G., Interleukin-6 CpG methylation and body weight correlate differently in type 2 diabetes patients compared to obese and lean controls. J. Nutrigenet. Nutrigenomics 8 (2015), 26–35, 10.1159/000381714.
2. Backhed, F., Ding, H., Wang, T., Hooper, L. V, Koh, G.Y., Nagy, A., et al. The gut microbiota as an environmental factor that regulates fat storage. Proc. Natl. Acad. Sci. U.S.A. 101 (2004), 15718–15723, 10.1073/pnas.0407076101.
3. Bellahcene, M., O'Dowd, J.F., Wargent, E.T., Zaibi, M.S., Hislop, D.C., Ngala, R.A., et al. Male mice that lack the G-protein-coupled receptor GPR41 have low energy expenditure and increased body fat content. Br. J. Nutr 109 (2013), 1755–1764, 10.1017/S0007114512003923.
4. Berg, R.D., The indigenous gastrointestinal microflora. Trends Microbiol 4 (1996), 430–435.
5. Bervoets, L., Van Hoorenbeeck, K., Kortleven, I., Van Noten, C., Hens, N., Vael, C., et al. Differences in gut microbiota composition between obese and lean children: a cross-sectional study. Gut Pathog, 5, 2013, 10, 10.1186/1757-4749-5-10.
6. Briscoe, C.P., Tadayyon, M., Andrews, J.L., Benson, W.G., Chambers, J.K., Eilert, M.M., et al. The orphan G protein-coupled receptor GPR40 is activated by medium and long chain fatty acids. J. Biol. Chem 278 (2003), 11303–11311, 10.1074/jbc.M211495200.
7. Canani, R., Di Costanzo, M., Leone, L., The epigenetic effects of butyrate: potential therapeutic implications for clinical practice. Clin. Epigenetics, 4, 2012, 4, 10.1186/1868-7083-4-4.
8. Cani, P.D., Delzenne, N.M., Interplay between obesity and associated metabolic disorders: new insights into the gut microbiota. Curr. Opin. Pharmacol 9 (2009), 737–743, 10.1016/j.coph.2009.06.016.
9. Cani, P.D., Amar, J., Iglesias, M.A., Poggi, M., Knauf, C., Bastelica, D., et al. Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes 56 (2007), 1761–1772, 10.2337/db06-1491.
10. Cani, P.D., Bibiloni, R., Knauf, C., Waget, A., Neyrinck, A.M., Delzenne, N.M., et al. Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice. Diabetes 57 (2008), 1470–1481, 10.2337/db07-1403.
11. Caricilli, A.M., Nascimento, P.H., Pauli, J.R., Tsukumo, D.M.L., Velloso, L.A., Carvalheira, J.B., et al. Inhibition of toll-like receptor 2 expression improves insulin sensitivity and signaling in muscle and white adipose tissue of mice fed a high-fat diet. J. Endocrinol 199 (2008), 399–406, 10.1677/JOE-08-0354.
12. Caricilli, A.M., Picardi, P.K., de Abreu, L.L., Ueno, M., Prada, P.O., Ropelle, E.R., et al. Gut microbiota is a key modulator of insulin resistance in TLR 2 knockout mice. PLoS Biol, 9, 2011, e1001212, 10.1371/journal.pbio.1001212.
13. Choi, S.W., Friso, S., Epigenetics: a new bridge between nutrition and health. Adv. Nutr 1 (2010), 8–16, 10.3945/an.110.10041004.
14. Clemente, J.C., Ursell, L.K., Parfrey, L.W., Knight, R., The impact of the gut microbiota on human health: an integrative view. Cell 148 (2012), 1258–1270, 10.1016/j.cell.2012.01.035.
15. Conterno, L., Fava, F., Viola, R., Tuohy, K.M., Obesity and the gut microbiota: does up-regulating colonic fermentation protect against obesity and metabolic disease?. Genes Nutr 6 (2011), 241–260, 10.1007/s12263-011-0230-1.
16. Creely, S.J., McTernan, P.G., Kusminski, C.M., Fisherf, M., Da Silva, N.F., Khanolkar, M., et al. Lipopolysaccharide activates an innate immune system response in human adipose tissue in obesity and type 2 diabetes. Am. J. Physiol. Endocrinol. Metab 292 (2007), E740–E747, 10.1152/ajpendo.00302.2006.
17. De Filippo, C., Cavalieri, D., Di Paola, M., Ramazzotti, M., Poullet, J.B., Massart, S., et al. Impact of diet in shaping gut microbiota revealed by a comparative study in children from Europe and rural Africa. Proc. Natl. Acad. Sci. U.S.A. 107 (2010), 14691–14696, 10.1073/pnas.1005963107.
18. Delzenne, N.M., Cani, P.D., Interaction between obesity and the gut microbiota: relevance in nutrition. Annu. Rev. Nutr 31 (2011), 15–31, 10.1146/annurev-nutr-072610-145146.
19. Duncan, S.H., Lobley, G.E., Holtrop, G., Ince, J., Johnstone, A.M., Louis, P., et al. Human colonic microbiota associated with diet, obesity and weight loss. Int. J. Obes. (Lond) 32 (2008), 1720–1724, 10.1038/ijo.2008.155.
20. Ganapathy, V., Thangaraju, M., Prasad, P.D., Martin, P.M., Singh, N., Transporters and receptors for short-chain fatty acids as the molecular link between colonic bacteria and the host. Curr. Opin. Pharmacol 13 (2013), 869–874, 10.1016/j.coph.2013.08.006.
21. Gill, S.R., Pop, M., Deboy, R.T., Eckburg, P.B., Turnbaugh, P.J., Samuel, B.S., et al. Metagenomic analysis of the human distal gut microbiome. Science 312 (2006), 1355–1359, 10.1126/science.1124234.
22. Glozak, M.A., Sengupta, N., Zhang, X., Seto, E., Acetylation and deacetylation of non-histone proteins. Gene 363 (2005), 15–23, 10.1016/j.gene.2005.09.010.
23. Hamer, H.M., Jonkers, D., Venema, K., Vanhoutvin, S., Troost, F.J., Brummer, R.-J., Review article: the role of butyrate on colonic function. Aliment. Pharmacol. Ther 27 (2008), 104–119, 10.1111/j.1365-2036.2007.03562.x.
24. Haslberger, A., Terkeltaub, R., Editorial: can GPR43 sensing of short-chain fatty acids unchain inflammasome-driven arthritis?. Arthritis Rheumatol 67 (2015), 1419–1423, 10.1002/art.39102.
25. Himes, R.W., Smith, C.W., Tlr2 is critical for diet-induced metabolic syndrome in a murine model. FASEB J. 24 (2010), 731–739, 10.1096/fj.09-141929.
26. Hippe, B., Zwielehner, J., Liszt, K., Lassl, C., Unger, F., Haslberger, A.G., Quantification of butyryl CoA:acetate CoA-transferase genes reveals different butyrate production capacity in individuals according to diet and age. FEMS Microbiol. Lett 316 (2011), 130–135, 10.1111/j.1574-6968.2010.02197.x.
27. Ichimura, A., Hasegawa, S., Kasubuchi, M., Kimura, I., Free fatty acid receptors as therapeutic targets for the treatment of diabetes. Front. Pharmacol, 5, 2014, 236, 10.3389/fphar.2014.00236.
28. Jobin, C., GPR109a: the missing link between microbiome and good health?. Immunity 40 (2014), 8–10, 10.1016/j.immuni.2013.12.009.
29. Kaji, I., Karaki, S., Kuwahara, A., Short-chain fatty acid receptor and its contribution to glucagon-like peptide-1 release. Digestion 89 (2014), 31–36, 10.1159/000356211.
30. Karlsson, C.L.J., Molin, G., Fåk, F., Johansson Hagslätt, M.-L., Jakesevic, M., Håkansson, Å., et al. Effects on weight gain and gut microbiota in rats given bacterial supplements and a high-energy-dense diet from fetal life through to 6 months of age. Br. J. Nutr 106 (2011), 887–895, 10.1017/S0007114511001036.
31. Karlsson, F.H., Ussery, D.W., Nielsen, J., Nookaew, I., A closer look at bacteroides: phylogenetic relationship and genomic implications of a life in the human gut. Microb. Ecol 61 (2010), 473–485, 10.1007/s00248-010-9796-1.
32. Kellermayer, R., Dowd, S.E., Harris, R.A., Balasa, A., Schaible, T.D., Wolcott, R.D., et al. Colonic mucosal DNA methylation, immune response, and microbiome patterns in Toll-like receptor 2-knockout mice. FASEB J. 25 (2011), 1449–1460, 10.1096/fj.10-172205.
33. Kern, P.A., Ranganathan, S., Li, C., Wood, L., Ranganathan, G., Adipose tissue tumor necrosis factor and interleukin-6 expression in human obesity and insulin resistance. Am. J. Physiol. Endocrinol. Metab 280 (2001), E745–E751.
34. Khan, M., Raoult, D., Richet, H., Lepidi, H., La Scola, B., Growth-promoting effects of single-dose intragastrically administered probiotics in chickens. Br. Poult. Sci 48 (2007), 732–735, 10.1080/00071660701716222.
35. Kim, J.J., Sears, D.D., TLR4 and insulin resistance. Gastroenterol. Res. Pract, 2010, 2010, 10.1155/2010/212563.
36. Kimura, I., Inoue, D., Maeda, T., Hara, T., Ichimura, A., Miyauchi, S., et al. Short-chain fatty acids and ketones directly regulate sympathetic nervous system via G protein-coupled receptor 41 (GPR41). Proc. Natl. Acad. Sci. U.S.A. 108 (2011), 8030–8035, 10.1073/pnas.1016088108.
37. Klose, R.J., Bird, A.P., Genomic DNA methylation: the mark and its mediators. Trends Biochem. Sci 31 (2006), 89–97, 10.1016/j.tibs.2005.12.008.
38. Kondo, T., Epigenetic alchemy for cell fate conversion. Curr. Opin. Genet. Dev 16 (2006), 502–507, 10.1016/j.gde.2006.07.001.
39. Liu, L., Li, L., Min, J., Wang, J., Wu, H., Zeng, Y., et al. Butyrate interferes with the differentiation and function of human monocyte-derived dendritic cells. Cell. Immunol 277 (2012), 66–73, 10.1016/j.cellimm.2012.05.011.
40. Louis, P., Flint, H.J., Development of a semiquantitative degenerate real-time PCR-based assay for estimation of numbers of butyryl-coenzyme A (CoA) CoA transferase genes in complex bacterial samples. Appl. Environ. Microbiol 73 (2007), 2009–2012, 10.1128/AEM.02561-06.
41. Louis, P., Scott, K.P., Duncan, S.H., Flint, H.J., Understanding the effects of diet on bacterial metabolism in the large intestine. J. Appl. Microbiol 102 (2007), 1197–1208, 10.1111/j.1365-2672.2007.03322.x.
42. Louis, P., Scott, K.P., Duncan, S.H., Flint, H.J., Understanding the effects of diet on bacterial metabolism in the large intestine. J. Appl. Microbiol 102 (2007), 1197–1208, 10.1111/j.1365-2672.2007.03322.x.
43. Macfarlane, S., Macfarlane, G.T., Regulation of short-chain fatty acid production. Proc. Nutr. Soc 62 (2003), 67–72, 10.1079/PNS2002207.
44. Macia, L., Tan, J., Vieira, A.T., Leach, K., Stanley, D., Luong, S., et al. Metabolite-sensing receptors GPR43 and GPR109A facilitate dietary fibre-induced gut homeostasis through regulation of the inflammasome. Nat. Commun, 6, 2015, 6734, 10.1038/ncomms7734.
45. Mariat, D., Firmesse, O., Levenez, F., Guimarăes, V., Sokol, H., Doré, J., et al. The Firmicutes/Bacteroidetes ratio of the human microbiota changes with age. BMC Microbiol, 9, 2009, 123, 10.1186/1471-2180-9-123.
46. Mazmanian, S.K., Round, J.L., Kasper, D.L., A microbial symbiosis factor prevents intestinal inflammatory disease. Nature 453 (2008), 620–625, 10.1038/nature07008.
47. Mehler, M.F., Mattick, J.S., Noncoding RNAs and RNA editing in brain development, functional diversification, and neurological disease. Physiol. Rev 87 (2007), 799–823, 10.1152/physrev.00036.2006.
48. Million, M., Angelakis, E., Paul, M., Armougom, F., Leibovici, L., Raoult, D., Comparative meta-analysis of the effect of Lactobacillus species on weight gain in humans and animals. Microb. Pathog 53 (2012), 100–108, 10.1016/j.micpath.2012.05.007.
49. Musso, G., Gambino, R., Cassader, M., Obesity, diabetes, and gut microbiota: the hygiene hypothesis expanded?. Diabetes Care 33 (2010), 2277–2284, 10.2337/dc10-0556.
50. Nagy-Szakal, D., Kellermayer, R., The remarkable capacity for gut microbial and host interactions. Gut Microbes 2 (2011), 178–182.
51. Nava, G.M., Stappenbeck, T.S., Diversity of the autochthonous colonic microbiota. Gut Microbes 2 (2011), 99–104, 10.4161/gmic.2.2.15416.
52. Park, J.-S., Lee, E.-J., Lee, J.-C., Kim, W.-K., Kim, H.-S., Anti-inflammatory effects of short chain fatty acids in IFN-gamma-stimulated RAW 264.7 murine macrophage cells: involvement of NF-kappaB and ERK signaling pathways. Int. Immunopharmacol 7 (2007), 70–77, 10.1016/j.intimp.2006.08.015.
53. Pryde, S.E., Duncan, S.H., Hold, G.L., Stewart, C.S., Flint, H.J., The microbiology of butyrate formation in the human colon. FEMS Microbiol. Lett 217 (2002), 133–139, 10.1016/S0378-1097(02)01106-0.
54. Qatanani, M., Lazar, M.A., Mechanisms of obesity-associated insulin resistance: many choices on the menu. Genes Dev 21 (2007), 1443–1455, 10.1101/gad.1550907.
55. Qin, J., Li, R., Raes, J., Arumugam, M., Burgdorf, K.S., Manichanh, C., et al. A human gut microbial gene catalogue established by metagenomic sequencing. Nature 464 (2010), 59–65, 10.1038/nature08821.
56. Remely, M., Aumueller, E., Merold, C., Dworzak, S., Hippe, B., Zanner, J., et al. Effects of short chain fatty acid producing bacteria on epigenetic regulation of FFAR3 in type 2 diabetes and obesity. Gene 537 (2013), 85–92, 10.1016/j.gene.2013.11.081.
57. Remely, M., Dworzak, S., Hippe, B., Zwielehner, J., Aumueller, E., Brath, H., et al. Abundance and diversity of microbiota in type 2 diabetes and obesity. J. Diabetes Metab, 4, 2013, 3.
58. Remely, M., Aumueller, E., Jahn, D., Hippe, B., Brath, H., Haslberger, A., Microbiota and epigenetic regulation of inflammatory mediators in type 2 diabetes and obesity. Benef. Microbes 5 (2014), 33–43, 10.3920/BM2013.006.
59. Remely, M., Aumueller, E., Jahn, D., Hippe, B., Brath, H., Haslberger, A., Microbiota and epigenetic regulation of inflammatory mediators in type 2 diabetes and obesity. Benef. Microbes 5 (2014), 33–43, 10.3920/BM2013.006.
60. Remely, M., Aumueller, E., Merold, C., Dworzak, S., Hippe, B., Zanner, J., et al. Effects of short chain fatty acid producing bacteria on epigenetic regulation of FFAR3 in type 2 diabetes and obesity. Gene 537 (2014), 85–92, 10.1016/j.gene.2013.11.081.
61. Ridaura, V.K., Faith, J.J., Rey, F.E., Cheng, J., Duncan, A.E., Kau, A.L., et al. Gut microbiota from twins discordant for obesity modulate metabolism in mice. Science, 341, 2013, 1241214, 10.1126/science.1241214.
62. Rieder, A., Rathmanner, T., Kiefer, I., Dorner, T., Kunze, M., Österreichischer Diabetesbericht 2004. Daten, Fakten, Strategien, 2004.
63. Robinson, E.L., Thompson, W.L., Council, N.R., Jeans, P.C., Marriott, W.M., Mitchell-Nelson, F., et al. Effect on weight gain of the addition of lactobacillus acidophilus to the formula of newborn infants. J. Pediatr 41 (1952), 395–398, 10.1016/S0022-3476(52)80121-0.
64. Shoelson, S.E., Lee, J., Goldfine, A.B., Inflammation and insulin resistance. J. Clin. Invest 116 (2006), 1793–1801, 10.1172/JCI29069.
65. Sommer, F., Bäckhed, F., The gut microbiota – masters of host development and physiology. Nat. Rev. Microbiol 11 (2013), 227–238, 10.1038/nrmicro2974.
66. Sonnenburg, E.D., Zheng, H., Joglekar, P., Higginbottom, S.K., Firbank, S.J., Bolam, D.N., et al. Specificity of polysaccharide use in intestinal bacteroides species determines diet-induced microbiota alterations. Cell 141 (2010), 1241–1252, 10.1016/j.cell.2010.05.005.
67. Staels, B., Fruchart, J.-C., Therapeutic roles of peroxisome proliferator-activated receptor agonists. Diabetes 54 (2005), 2460–2470.
68. Sullivan, K.E., Reddy, A.B.M., Dietzmann, K., Suriano, A.R., Kocieda, V.P., Stewart, M., et al. Epigenetic regulation of tumor necrosis factor alpha. Mol. Cell. Biol 27 (2007), 5147–5160, 10.1128/MCB.02429-06.
69. Suzuki, K., Jayasena, C.N., Bloom, S.R., The gut hormones in appetite regulation. J. Obes, 2011, 2011, 528401, 10.1155/2011/528401.
70. Takahashi, K., Sugi, Y., Nakano, K., Tsuda, M., Kurihara, K., Hosono, A., et al. Epigenetic control of the host gene by commensal bacteria in large intestinal epithelial cells. J. Biol. Chem 286 (2011), 35755–35762, 10.1074/jbc.M111.271007.
71. Tammen, S.A., Friso, S., Choi, S.-W., Epigenetics: the link between nature and nurture. Mol. Aspects Med 34 (2013), 753–764, 10.1016/j.mam.2012.07.018.
72. Tan, J., McKenzie, C., Potamitis, M., Thorburn, A.N., Mackay, C.R., Macia, L., The role of short-chain fatty acids in health and disease. Adv. Immunol 121 (2014), 91–119, 10.1016/B978-0-12-800100-4.00003-9.
73. Thangaraju, M., Cresci, G.A., Liu, K., Ananth, S., Gnanaprakasam, J.P., Browning, D.D., et al. GPR109A is a G-protein-coupled receptor for the bacterial fermentation product butyrate and functions as a tumor suppressor in colon. Cancer Res 69 (2009), 2826–2832, 10.1158/0008-5472.CAN-08-4466.
74. Tremaroli, V., Bäckhed, F., Functional interactions between the gut microbiota and host metabolism. Nature 489 (2012), 242–249, 10.1038/nature11552.
75. Tsankova, N., Renthal, W., Kumar, A., Nestler, E.J., Epigenetic regulation in psychiatric disorders. Nat. Rev. Neurosci 8 (2007), 355–367, 10.1038/nrn2132.
76. Tsukumo, D.M.L., Carvalho-Filho, M.A., Carvalheira, J.B.C., Prada, P.O., Hirabara, S.M., Schenka, A.A., et al. Loss-of-function mutation in Toll-like receptor 4 prevents diet-induced obesity and insulin resistance. Diabetes 56 (2007), 1986–1998, 10.2337/db06-1595.
77. Tunaru, S., Kero, J., Schaub, A., Wufka, C., Blaukat, A., Pfeffer, K., et al. PUMA-G and HM74 are receptors for nicotinic acid and mediate its anti-lipolytic effect. Nat. Med 9 (2003), 352–355, 10.1038/nm824.
78. Vieira, E.L.M., Leonel, A.J., Sad, A.P., Beltrão, N.R.M., Costa, T.F., Ferreira, T.M.R., et al. Oral administration of sodium butyrate attenuates inflammation and mucosal lesion in experimental acute ulcerative colitis. J. Nutr. Biochem 23 (2012), 430–436, 10.1016/j.jnutbio.2011.01.007.
79. Vinolo, M.A.R., Ferguson, G.J., Kulkarni, S., Damoulakis, G., Anderson, K., Bohlooly-Y, M., et al. SCFAs induce mouse neutrophil chemotaxis through the GPR43 receptor. PLoS ONE, 6, 2011, e21205, 10.1371/journal.pone.0021205.
80. Wichmann, A., Allahyar, A., Greiner, T.U., Plovier, H., Lundén, G.Ö., Larsson, T., et al. Microbial modulation of energy availability in the colon regulates intestinal transit. Cell Host Microbe 14 (2013), 582–590, 10.1016/j.chom.2013.09.012.
81. World Health Statistics, http://www.who.int/gho/publications/world_health_statistics/2015/en/, 2015.
82. Wrzosek, L., Miquel, S., Noordine, M.-L., Bouet, S., Chevalier-Curt, M., Robert, V., et al. Bacteroides thetaiotaomicron and Faecalibacterium prausnitzii influence the production of mucus glycans and the development of goblet cells in the colonic epithelium of a gnotobiotic model rodent. BMC Biol, 11, 2013, 61, 10.1186/1741-7007-11-61.
83. Wu, G.D., Chen, J., Hoffmann, C., Bittinger, K., Chen, Y.-Y., Keilbaugh, S.A., et al. Linking long-term dietary patterns with gut microbial enterotypes. Science 334 (2011), 105–108, 10.1126/science.1208344.
84. Wu, J., Zhou, Z., Hu, Y., Dong, S., Butyrate-induced GPR41 activation inhibits histone acetylation and cell growth. J. Genet. Genomics 39 (2012), 375–384, 10.1016/j.jgg.2012.05.008.
85. Xiong, Y., Miyamoto, N., Shibata, K., Valasek, M.A., Motoike, T., Kedzierski, R.M., et al. Short-chain fatty acids stimulate leptin production in adipocytes through the G protein-coupled receptor GPR41. Proc. Natl. Acad. Sci. U.S.A. 101 (2004), 1045–1050, 10.1073/pnas.2637002100.
86. Xu, J., Mahowald, M.A., Ley, R.E., Lozupone, C.A., Hamady, M., Martens, E.C., et al. Evolution of symbiotic bacteria in the distal human intestine. PLoS Biol, 5, 2007, e156, 10.1371/journal.pbio.0050156.
87. Zhang, H., DiBaise, J.K., Zuccolo, A., Kudrna, D., Braidotti, M., Yu, Y., et al. Human gut microbiota in obesity and after gastric bypass. Proc. Natl. Acad. Sci. U.S.A. 106 (2009), 2365–2370, 10.1073/pnas.0812600106.